在老年人群的关节整形术期间,口服中林用于预防脊椎后麻醉低血压:随机对照试验
Sarah Amin1, Ahmed Hasanin2, Rehab Mansour1
1Department of Anesthesia and Critical Care Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
BMC anesthesiology
|February 14, 2024
概括
在接受脊椎麻醉部手术的老年患者中,米多德林有效降低了低血压和血管压缩剂的需求. 这种预防措施通过降低脊柱后低血压的发生率,改善了患者的治疗结果.
科学领域:
- 麻醉学 麻醉学
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊柱后麻醉低血压是一种常见的并发症,特别是在接受关节整形手术的老年患者中.
- 管理低血压需要干预措施,如血管压缩剂的管理,影响患者的康复.
研究的目的:
- 为了评估米多德林作为预防性药物对脊柱后低血压的疗效.
- 评估midodrine对这种患者群体的血管压缩剂要求和血液动力稳定性的影响.
主要方法:
- 一项随机对照试验,涉及老年患者在脊髓麻醉下接受关节整形手术.
- 患者在手术前90分钟接受了5mg口服米多德林或安慰剂 (美托克洛普拉米德).
- 密切监测了平均动脉压和心率,低血压定义为MAP<基线80%并用以弗德林治疗.
主要成果:
- 与对照组相比,midodrine组的手术内以弗德林消耗显著降低 (10 mg vs. 30 mg).
- 在接受 midodrine 的患者中,手术内低血压的发生率也显著降低.
- 两组之间不存在勃心脏或高血压发病率的显著差异.
结论:
- 5毫克口服米多德林的预防性使用有效地降低了血管压缩剂的需求和老年患者部手术后脊髓麻醉后低血压的发生率.
- 米多德林代表了一种可行的策略,可以改善血液动力学管理,并可能减少这一人口群体的并发症.
相关概念视频
Local Anesthetics: Clinical Application as Spinal Anesthesia
629
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
629
Skeletal Muscle Relaxants: Therapeutic Uses
486
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
486
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Cholinergic Antagonists: Therapeutic Uses
749
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
749
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
421
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
421
Direct-Acting Cholinergic Agonists: Therapeutic Uses
743
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
743


